Synthesis of highly potent lymphocyte function-associated antigen-1 antagonists labeled with carbon-14 and with stable isotopes, part 3

J Labelled Comp Radiopharm. 2019 Feb;62(2):77-85. doi: 10.1002/jlcr.3698. Epub 2018 Dec 12.

Abstract

The drug candidates (2) and (3) are highly potent LFA-1 inhibitors. They were efficiently prepared labeled with carbon-14 using a palladium-catalyzed carboxylation of an iodo-precursor (5) and sodium formate-14 C to afford acid [14 C]-(6), which was coupled via an amide bond to chiral amines (7) and (8) in 52% and 48% overall yield, respectively, and with specific activities higher than 56 mCi/mmol and radiochemical purities of 99%. For stable isotopes synthesis, the amine [2 H8 ]-(7) was synthesized in three steps from 2-cyanopyridine-2 H4 using Kulinkovich-Szymonik aminocyclopropanation, followed by coupling to L-alanine-2,3,3,3-2 H4 -N-t-BOC, and then removal of the BOC-protecting group. Amide bond formation with acid (6) gave [2 H8 ]-(2) in 36% overall yield. The amine [13 C4 ,15 N]-(8) was obtained in two steps using L-threonine-14 C4 ,15 N and then coupled to acid [13 C]-(6) to give [13 C5 ,15 N]-(3) in 56% overall yield.

Keywords: LFA-1; carbon-13; carbon-14; deuterium; nitrogen-15; radiosynthesis.

MeSH terms

  • Carbon Radioisotopes / chemistry*
  • Lymphocyte Function-Associated Antigen-1 / metabolism*
  • Protein Binding
  • Radiopharmaceuticals / chemical synthesis*
  • Radiopharmaceuticals / pharmacology

Substances

  • Carbon Radioisotopes
  • Lymphocyte Function-Associated Antigen-1
  • Radiopharmaceuticals